Purchase Order N3239825P0116

Award Date 5/7/25
Potential Completion Date 4/2/26
Potential Value $53K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20910, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Roche Diagnostics Corporation (doing business as Roche Diagnostics Corp), a foreign-owned, for-profit manufacturer of medical diagnostic products, is for the delivery of test kits and sets to the Department of the Navy Bureau of Medicine and Surgery. The $248,190.00 firm-fixed-price purchase order has a completion date of June 2, 2021. The contract does not have a set-aside designation. Roche Diagnostics has a history of providing critical care analyzers, reagents,...
This is a $787,038.78 firm fixed-price delivery order contract awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics and medical products. The contract, which has no set-aside designation, provides for the delivery of Roche's medical diagnostic technologies, including laboratory equipment, testing systems, reagents, and clinical testing services, to support...
This is a delivery order issued by the Department of Veterans Affairs (VA), Veterans Integrated Service Network 9 to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $66,900.00 firm fixed price contract is for the delivery of influenza A/B and COVID-19 testing supplies and services under the "EXERCISE OY4 BASE PLUS OPTIONS" requirement. The...
The Department of Veterans Affairs (VA) awarded a $132,686.76 firm-fixed-price delivery order to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory equipment. The contract, which was not set aside, was issued under the VA's Veterans Integrated Service Network 12 and will provide molecular pathology services to support the VA's COVID-19 response efforts. Roche Diagnostics has a history of supplying critical medical equipment,...
This firm fixed-price purchase order was awarded by the Defense Health Agency to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract, with a potential value of $230,895.88, is for the provision of immunoassay services on a per-reportable-result basis, with a completion date of April 30, 2022. Roche Diagnostics has a history of providing critical care analyzers,...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Roche Diagnostics Corporation for $33,063.35. The contract is for reagents required for staining histological samples in flu research, with a completion date of September 26, 2024. The contract has no set-aside designation. Roche Diagnostics Corporation is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and...
This is a $60,417.98 firm fixed-price delivery order awarded by the Federal Medical Center Rochester, a civilian agency, to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostic products and laboratory equipment. The award is for FY25 B5 ROCHE MO. SERVICE AND REAGENT APR 25 PR 0170 and has an ultimate completion date of May 8, 2025. The contract is not designated as a set-aside. Roche Diagnostics holds multiple Indefinite Delivery Vehicles (IDVs) and...
The Department of Veterans Affairs Veterans Health Administration has awarded a firm fixed-price delivery order to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer, to provide influenza A/B and COVID-19 testing supplies and services. The one-year order, valued at $67,881.98, supports the Veterans Integrated Service Network 9 in Castleton, Indiana. Roche Diagnostics, which holds multiple General Services Administration schedule contracts and other Indefinite Delivery...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed-price purchase order to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer and distributor of in vitro diagnostics, reagents, and laboratory equipment. The $105,921.20 contract is for sample reagents with a completion date of November 7, 2022. This award was not set aside for any socioeconomic category. Roche Diagnostics has held numerous federal contracts, including...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), an institute within the Department of Health and Human Services, to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp. The $4,380.08 contract is for the provision of detection kits and supplies to be used with the Discovery Ultra Stainer. The contract has no set-aside designation. Roche Diagnostics, a foreign-owned, for-profit manufacturer of in...

This is a $52,920.00 firm fixed-price purchase order contract awarded by the United States Department of the Naval Medical Research Command (NMRC) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics. The contract is for a drop shipment of specialized laboratory supplies, including extraction reagents for COVID-19, Influenza A/B, Seasonal Influenza A subtyping, and Influenza A/H5 and Influenza A/H7 diagnostic testing. The supplies are needed by the Naval Infectious Diseases Diagnostic Laboratory. The contract includes six bi-monthly shipments between June 2025 and April 2026, with each shipment consisting of 1,000 extraction reactions. This sole source contract is being awarded under Federal Acquisition Regulation (FAR) Part 12 Commercial Items and does not have a set-aside designation.

Generated 8/3/25, 12:54 AM